vs
Marqeta, Inc.（MQ）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Marqeta, Inc.的1.3倍（$219.9M vs $172.1M），Marqeta, Inc.同比增速更快（26.7% vs 2.0%），Marqeta, Inc.自由现金流更多（$53.2M vs $16.8M），过去两年Marqeta, Inc.的营收复合增速更高（20.8% vs 8.0%）
Marqeta, Inc.运营云原生开放API平台，提供现代发卡与数字支付处理服务，可赋能金融科技初创企业、大型零售商及企业客户推出定制化实体、虚拟支付卡及嵌入式金融解决方案，服务覆盖全球消费及商业市场。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
MQ vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.3倍
$172.1M
营收增速更快
MQ
高出24.8%
2.0%
自由现金流更多
MQ
多$36.3M
$16.8M
两年增速更快
MQ
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $172.1M | $219.9M |
| 净利润 | — | $-2.2M |
| 毛利率 | 69.7% | 71.1% |
| 营业利润率 | -4.8% | 0.2% |
| 净利率 | — | -1.0% |
| 营收同比 | 26.7% | 2.0% |
| 净利润同比 | — | 92.4% |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MQOFIX
| Q4 25 | $172.1M | $219.9M | ||
| Q3 25 | $163.3M | $205.6M | ||
| Q2 25 | $150.4M | $203.1M | ||
| Q1 25 | $139.1M | $193.6M | ||
| Q4 24 | $135.8M | $215.7M | ||
| Q3 24 | $128.0M | $196.6M | ||
| Q2 24 | $125.3M | $198.6M | ||
| Q1 24 | $118.0M | $188.6M |
净利润MQOFIX
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $-3.6M | $-22.8M | ||
| Q2 25 | $-647.0K | $-14.1M | ||
| Q1 25 | $-8.3M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $-28.6M | $-27.4M | ||
| Q2 24 | $119.1M | $-33.4M | ||
| Q1 24 | $-36.1M | $-36.0M |
毛利率MQOFIX
| Q4 25 | 69.7% | 71.1% | ||
| Q3 25 | 70.1% | 72.2% | ||
| Q2 25 | 69.2% | 68.7% | ||
| Q1 25 | 71.0% | 62.8% | ||
| Q4 24 | 72.3% | 69.0% | ||
| Q3 24 | 70.4% | 68.7% | ||
| Q2 24 | 63.3% | 67.8% | ||
| Q1 24 | 71.3% | 67.5% |
营业利润率MQOFIX
| Q4 25 | -4.8% | 0.2% | ||
| Q3 25 | -6.4% | -8.3% | ||
| Q2 25 | -6.1% | -7.9% | ||
| Q1 25 | -13.3% | -25.2% | ||
| Q4 24 | -27.6% | -5.3% | ||
| Q3 24 | -33.0% | -9.6% | ||
| Q2 24 | 83.9% | -12.5% | ||
| Q1 24 | -42.3% | -15.6% |
净利率MQOFIX
| Q4 25 | — | -1.0% | ||
| Q3 25 | -2.2% | -11.1% | ||
| Q2 25 | -0.4% | -6.9% | ||
| Q1 25 | -5.9% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | -22.4% | -13.9% | ||
| Q2 24 | 95.1% | -16.8% | ||
| Q1 24 | -30.6% | -19.1% |
每股收益（稀释后）MQOFIX
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.57 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | — | $-0.71 | ||
| Q2 24 | — | $-0.88 | ||
| Q1 24 | — | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $709.4M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $762.0M | $450.0M |
| 总资产 | $1.5B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MQOFIX
| Q4 25 | $709.4M | $82.0M | ||
| Q3 25 | $747.2M | $62.9M | ||
| Q2 25 | $732.7M | $65.6M | ||
| Q1 25 | $830.9M | $58.0M | ||
| Q4 24 | $923.0M | $83.2M | ||
| Q3 24 | $886.4M | $30.1M | ||
| Q2 24 | $924.7M | $26.4M | ||
| Q1 24 | $970.4M | $27.0M |
总债务MQOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益MQOFIX
| Q4 25 | $762.0M | $450.0M | ||
| Q3 25 | $839.2M | $442.5M | ||
| Q2 25 | $843.4M | $458.3M | ||
| Q1 25 | $987.3M | $458.3M | ||
| Q4 24 | $1.1B | $503.1M | ||
| Q3 24 | $1.1B | $525.9M | ||
| Q2 24 | $1.1B | $546.0M | ||
| Q1 24 | $1.2B | $570.3M |
总资产MQOFIX
| Q4 25 | $1.5B | $850.6M | ||
| Q3 25 | $1.5B | $832.6M | ||
| Q2 25 | $1.2B | $837.2M | ||
| Q1 25 | $1.3B | $823.1M | ||
| Q4 24 | $1.5B | $893.3M | ||
| Q3 24 | $1.4B | $867.9M | ||
| Q2 24 | $1.5B | $882.0M | ||
| Q1 24 | $1.6B | $906.0M |
负债/权益比MQOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $53.2M | $16.8M |
| 自由现金流率自由现金流/营收 | 30.9% | 7.6% |
| 资本支出强度资本支出/营收 | 0.1% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $160.5M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流MQOFIX
| Q4 25 | $53.3M | $27.7M | ||
| Q3 25 | $86.8M | $12.4M | ||
| Q2 25 | $12.5M | $11.6M | ||
| Q1 25 | $10.0M | $-18.4M | ||
| Q4 24 | $24.8M | $23.7M | ||
| Q3 24 | $7.3M | $11.7M | ||
| Q2 24 | $25.7M | $9.0M | ||
| Q1 24 | $426.0K | $-18.6M |
自由现金流MQOFIX
| Q4 25 | $53.2M | $16.8M | ||
| Q3 25 | $86.4M | $2.5M | ||
| Q2 25 | $12.2M | $4.5M | ||
| Q1 25 | $8.7M | $-25.1M | ||
| Q4 24 | $24.7M | $15.2M | ||
| Q3 24 | $7.1M | $6.3M | ||
| Q2 24 | $24.7M | $-360.0K | ||
| Q1 24 | $-765.0K | $-29.1M |
自由现金流率MQOFIX
| Q4 25 | 30.9% | 7.6% | ||
| Q3 25 | 52.9% | 1.2% | ||
| Q2 25 | 8.1% | 2.2% | ||
| Q1 25 | 6.3% | -13.0% | ||
| Q4 24 | 18.2% | 7.0% | ||
| Q3 24 | 5.5% | 3.2% | ||
| Q2 24 | 19.7% | -0.2% | ||
| Q1 24 | -0.6% | -15.4% |
资本支出强度MQOFIX
| Q4 25 | 0.1% | 4.9% | ||
| Q3 25 | 0.2% | 4.8% | ||
| Q2 25 | 0.2% | 3.5% | ||
| Q1 25 | 0.9% | 3.5% | ||
| Q4 24 | 0.0% | 4.0% | ||
| Q3 24 | 0.1% | 2.7% | ||
| Q2 24 | 0.8% | 4.7% | ||
| Q1 24 | 1.0% | 5.6% |
现金转化率MQOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.22× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MQ
| Platform Service Revenue Net | $163.4M | 95% |
| Other Services Revenue | $8.8M | 5% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
